Weiss Multi Strategy Advisers LLC Cv Rx, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $19,885 - $56,249	-1,704 Reduced 14.56%	10,000 $314,000
Q3 2023 Nov 14, 2023	SELL	$13.56 - $18.47 $566,414 - $771,510	-41,771 Reduced 78.11%	11,704 $178,000
Q2 2023 Aug 14, 2023	BUY	$8.57 - $15.44 $247,732 - $446,324	28,907 Added 117.66%	53,475 $826,000
Q1 2023 May 15, 2023	SELL	$7.08 - $19.4 $162,535 - $445,365	-22,957 Reduced 48.31%	24,568 $229,000
Q4 2022 Feb 14, 2023	SELL	$8.94 - $18.35 $15,054 - $30,901	-1,684 Reduced 3.42%	47,525 $872,000
Q3 2022 Nov 14, 2022	SELL	$6.12 - $9.5 $5,771 - $8,958	-943 Reduced 1.88%	49,209 $459,000
Q2 2022 Aug 15, 2022	SELL	$4.7 - $7.22 $50,957 - $78,279	-10,842 Reduced 17.78%	50,152 $301,000
Q1 2022 May 16, 2022	BUY	$5.62 - $12.37 $50,939 - $112,121	9,064 Added 17.45%	60,994 $365,000
Q4 2021 Feb 14, 2022	BUY	$10.65 - $18.61 $45,219 - $79,018	4,246 Added 8.9%	51,930 $635,000
Q3 2021 Nov 15, 2021	BUY	$14.65 - $26.07 $382,130 - $680,009	26,084 Added 120.76%	47,684 $789,000
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $604,800 - $604,800	21,600 New	21,600 $605,000

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $355M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.